Jan 4 (Reuters) - Pharmaceutical maker Eli Lilly and Co. said on Friday it expects to increase profits in 2013, primarily due to cost controls and productivity gains off of a much weaker 2012 when sa…
Dec 28 (Reuters) - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb Co and Pfizer Inc, for treatment in patients with atrial fibrillation, or irregular…
WASHINGTON, Dec 20 (Reuters) - U.S. drugmaker Eli Lilly and Co agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government official…
* No financial details given (Adds details, background, Merial CEO comment)…
